The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating tumor DNA (ctDNA), failed to accrue enough patients ...
The rear panel houses an “Intel Inside” logo alongside a redundant Intel sticker ... He holds a Master’s degree in Wireless & Wired Telecommunications, Electrical Engineering, and Computer Informatics ...